PDE2A-IN-1 is primarily utilized in research settings to study the role of phosphodiesterase 2A (PDE2A) in various biological processes. It is often employed as a selective inhibitor to investigate the enzyme's involvement in cellular signaling pathways, particularly those related to cyclic nucleotides like cAMP and cGMP. This compound is valuable in understanding PDE2A's impact on neurological functions, including memory, learning, and mood regulation, making it a potential tool for exploring therapeutic targets for cognitive disorders and psychiatric conditions. Additionally, PDE2A-IN-1 is used in pharmacological studies to assess its efficacy and selectivity in modulating PDE2A activity, contributing to the development of novel drugs for treating diseases associated with PDE2A dysregulation.